[TVTX] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
04-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -28.91%
YoY- -198.88%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 47,769 39,570 38,432 33,620 29,008 17,372 28 245.28%
PBT -18,168 -40,576 -18,149 -13,154 6,146 -366 -70,560 -20.22%
Tax -18,976 401 229 -2,064 -5,070 -40,021 65 -
NP 808 -40,977 -18,378 -11,090 11,216 39,655 -70,626 -
Tax Rate - - - - 82.49% - - -
Total Cost 46,961 80,547 56,810 44,710 17,792 -22,283 70,654 -6.57%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 1.69 -103.56 -47.82 -32.99 38.67 228.27 -253,138.80 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS 0.02 -0.99 -0.46 -0.29 0.31 1.46 -3.03 -
EPS Diluted 0.02 -0.99 -0.46 -0.28 -0.08 1.32 -3.03 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.